Trials / Terminated
TerminatedNCT00954603
A Double-blind, Randomized, Controlled Trial of Quetiapine Versus Haloperidol for the Treatment of Delirium
Compare Efficacy and Safety Between Quetiapine and Haloperidol in Treatment Delirium
- Status
- Terminated
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 52 (actual)
- Sponsor
- Chiang Mai University · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether quetiapine, and haloperidol are effective and safe in the treatment psychiatric symptoms in patients with delirium.
Detailed description
A delirious state often founds in general hospitals and remains a significant cause of death. Existing methods of treatment includes identification and elimination of factors contributing to the delirium in addition to pharmacological and nonpharmacological treatment interventions (Trzepacz et al., 1999). Antipsychotics can play an important role in the management of the symptoms of delirium.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | quetiapine | 25-100 mg |
| DRUG | haloperidol | 0.5-2 mg |
Timeline
- Start date
- 2009-06-01
- Primary completion
- 2011-04-01
- Completion
- 2012-07-01
- First posted
- 2009-08-07
- Last updated
- 2011-06-23
Locations
1 site across 1 country: Thailand
Source: ClinicalTrials.gov record NCT00954603. Inclusion in this directory is not an endorsement.